Epigenetic Control of Ribosome Biogenesis Homeostasis Jerôme Deraze

Total Page:16

File Type:pdf, Size:1020Kb

Epigenetic Control of Ribosome Biogenesis Homeostasis Jerôme Deraze Epigenetic control of ribosome biogenesis homeostasis Jerôme Deraze To cite this version: Jerôme Deraze. Epigenetic control of ribosome biogenesis homeostasis. Cellular Biology. Université Pierre et Marie Curie - Paris VI, 2017. English. NNT : 2017PA066342. tel-01878354 HAL Id: tel-01878354 https://tel.archives-ouvertes.fr/tel-01878354 Submitted on 21 Sep 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Université Pierre et Marie Curie Ecole doctorale : Complexité du Vivant IBPS – UMR7622 Laboratoire de Biologie du Développement UPMC CNRS Epigenetic control of developmental homeostasis and plasticity Epigenetic Control of Ribosome Biogenesis Homeostasis Par Jérôme Deraze Thèse de doctorat de Biologie Moléculaire et Cellulaire Dirigée par Frédérique Peronnet et Sébastien Bloyer Présentée et soutenue publiquement le 19 Septembre 2017 Devant un jury composé de : Pr Anne-Marie MARTINEZ Professeur Rapporteur Dr Jacques MONTAGNE Directeur de Recherche Rapporteur Dr Olivier JEAN-JEAN Directeur de Recherche Examinateur Dr Michel COHEN-TANNOUDJI Directeur de Recherche Examinateur Dr Françoise JAMEN Maître de Conférences Examinateur Dr Nicolas NEGRE Maître de Conférences Examinateur Dr Frédérique PERONNET Directrice de Recherche Directrice de thèse Pr Sébastien BLOYER Professeur Co-directeur de thèse Table of contents Table of contents ..................................................................................................................................... 2 Table of figures ........................................................................................................................................ 5 Table of abreviations ............................................................................................................................... 7 Introduction ........................................................................................................................................... 11 I. The ribosome .................................................................................................................................. 12 A. Ribosome and translation ......................................................................................................... 12 1. Composition of the ribosome ...................................................................................... 13 2. Translation initiation ................................................................................................................. 15 3. Translation elongation ........................................................................................................... 17 4. Translation termination ......................................................................................................... 19 B. Ribosome biogenesis ................................................................................................................ 19 1. Ribosomal RNA transcription ................................................................................................ 19 2. Ribosomal RNA processing .................................................................................................... 23 3. rRNA modifications and snoRNPs .......................................................................................... 25 4. Ribosomal proteins biogenesis .............................................................................................. 27 5. Ribosomal protein assembly ................................................................................................. 29 6. Pre-ribosomal factors and quality control ............................................................................. 31 7. tRNA biogenesis ..................................................................................................................... 33 II. Ribosome biogenesis as a conductor of cell metabolism.............................................................. 35 A. Metabolic cues dictate the activity of ribosome synthesis ....................................................... 35 1. Cell growth and proliferation signals..................................................................................... 36 2. The cell cycle .......................................................................................................................... 39 3. Energy levels .......................................................................................................................... 42 4. Metabolic stress .................................................................................................................... 45 B. Ribosome biogenesis regulates homeostasis ............................................................................ 49 1. Ribosome biogenesis is monitored at several stages of cell life ........................................... 49 2. Ribosome biogenesis drives cellular organization ................................................................ 53 3. Phenotypic consequences of ribosome biogenesis defects .................................................. 56 III. Ribosomes regulate gene expression: the second lives of the housekeepers ............................. 61 A. Ribosome-mediated regulation of translation .......................................................................... 61 1. Ribosomes interact with mRNA cis-regulatory elements...................................................... 61 2. Trans-acting factors control translation ................................................................................ 67 3. Ribosome heterogeneity ....................................................................................................... 71 B. Extra-ribosomal functions of r-proteins .................................................................................... 77 2 1. When are r-proteins free? ..................................................................................................... 77 2. r-proteins participate in cell metabolism .............................................................................. 82 3. r-proteins are bound to chromatin ....................................................................................... 85 IV. Regulation of ribosome homeostasis by uL11 and Corto ............................................................ 89 A. The ribosomal protein uL11 ...................................................................................................... 89 1. General features of Drosophila uL11 .................................................................................... 90 2. Known functions of uL11 on and off the ribosome ............................................................... 92 3. Methylation of uL11 .............................................................................................................. 95 B. The transcription factor corto ................................................................................................... 97 1. General features of Corto ...................................................................................................... 97 2. corto participates in epigenetic maintenance of segmental identity during development. ................................................................................................................................................. 100 3. corto may be involved in developmental homeostasis ....................................................... 101 V. Presentation of the thesis project ............................................................................................... 103 Results ................................................................................................................................................. 106 I. Ribosomal protein uL11 tri-methylated on lysine 3 binds broad genomic regions and displays an exclusion pattern with Corto on chromatin. ................................................................................... 106 A. Results ................................................................................................................................. 107 B. Discussion ................................................................................................................................ 119 C. Materials and methods ........................................................................................................... 122 II. Editing essential genes: a marker independent CRISPR mutagenesis strategy. ......................... 127 A. Overview ................................................................................................................................. 127 B. Article ...................................................................................................................................... 127 C. Complementary data ............................................................................................................... 165 III. Mutation of a single amino-acid on ribosomal protein uL11 generates a Minute-like phenotype in Drosophila.
Recommended publications
  • The DEAD-Box RNA Helicase-Like Utp25 Is an SSU Processome Component
    Downloaded from rnajournal.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press The DEAD-box RNA helicase-like Utp25 is an SSU processome component J. MICHAEL CHARETTE1,2 and SUSAN J. BASERGA1,2,3 1Department of Molecular Biophysics & Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520, USA 2Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA 3Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520, USA ABSTRACT The SSU processome is a large ribonucleoprotein complex consisting of the U3 snoRNA and at least 43 proteins. A database search, initiated in an effort to discover additional SSU processome components, identified the uncharacterized, conserved and essential yeast nucleolar protein YIL091C/UTP25 as one such candidate. The C-terminal DUF1253 motif, a domain of unknown function, displays limited sequence similarity to DEAD-box RNA helicases. In the absence of the conserved DEAD-box sequence, motif Ia is the only clearly identifiable helicase element. Since the yeast homolog is nucleolar and interacts with components of the SSU processome, we examined its role in pre-rRNA processing. Genetic depletion of Utp25 resulted in slowed growth. Northern analysis of pre-rRNA revealed an 18S rRNA maturation defect at sites A0,A1, and A2. Coimmunoprecipitation confirmed association with U3 snoRNA and with Mpp10, and with components of the t-Utp/UtpA, UtpB, and U3 snoRNP subcomplexes. Mutation of the conserved motif Ia residues resulted in no discernable temperature- sensitive or cold-sensitive growth defects, implying that this motif is dispensable for Utp25 function.
    [Show full text]
  • Proteotoxicity from Aberrant Ribosome Biogenesis Compromises Cell Fitness
    Proteotoxicity From Aberrant Ribosome Biogenesis Compromises Cell Fitness The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Tye, Blake Wells. 2019. Proteotoxicity From Aberrant Ribosome Biogenesis Compromises Cell Fitness. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:42013104 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Proteotoxicity from Aberrant Ribosome Biogenesis Compromises Cell Fitness A dissertation presented by Blake Wells Tye to The Committee on Higher Degrees in Chemical Biology in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Chemical Biology Harvard University Cambridge, Massachusetts May 2019 © 2019 Blake Wells Tye All rights reserved. Dissertation Advisor: Author: L. Stirling Churchman, PhD Blake Wells Tye Proteotoxicity from Aberrant Ribosome Biogenesis Compromises Cell Fitness Abstract Proteins are the workhorses of the cell, carrying out much of the structural and enzymatic work of life. Many proteins function as part of greater assemblies, or complexes, with other proteins and/or biomolecules. As the cell grows and divides, it must double its proteome, which requires synthesis and folding of individual proteins, assembly into complexes, and proper subcellular localization. This is repeated for millions of proteins molecules compromising thousands of potential assemblies, making up a rather tricky set of tasks for cells to carry out simultaneously.
    [Show full text]
  • Cryo-EM Structure of the RNA-Rich Plant Mitochondrial Ribosome
    bioRxiv preprint doi: https://doi.org/10.1101/777342; this version posted September 20, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cryo-EM structure of the RNA-rich plant mitochondrial ribosome Florent Waltz1* & Heddy Soufari1*, Anthony Bochler1, Philippe Giegé2+ & Yaser Hashem1+ 1 Institut Européen de Chimie et Biologie, U1212 Inserm, Université de Bordeaux, 2 rue R. Escarpit, F- 33600 Pessac, France 2Institut de biologie de moléculaire des plantes, UPR 2357 du CNRS, Université de Strasbourg, 12 rue du général Zimmer, F-67084 Strasbourg, France *equally contributing authors +corresponding authors The vast majority of eukaryotic cells contain mitochondria, essential powerhouses and metabolic hubs1. These organelles have a bacterial origin and were acquired during an early endosymbiosis event2. Mitochondria possess specialized gene expression systems composed of various molecular machines including the mitochondrial ribosomes (mitoribosomes). Mitoribosomes are in charge of translating the few essential mRNAs still encoded by mitochondrial genomes3. While chloroplast ribosomes strongly resemble those of bacteria4,5, mitoribosomes have diverged significantly during evolution and present strikingly different structures across eukaryotic species6–10. In contrast to animals and trypanosomatides, plants mitoribosomes have unusually expanded ribosomal RNAs and conserved the short 5S rRNA, which is usually missing in mitoribosomes11. We have previously characterized the composition of the plant mitoribosome6 revealing a dozen plant-specific proteins, in addition to the common conserved mitoribosomal proteins. In spite of the tremendous recent advances in the field, plant mitoribosomes remained elusive to high-resolution structural investigations, and the plant-specific ribosomal features of unknown structures.
    [Show full text]
  • In Vitro Comparison of Initiation Properties of Bacteriophage X Wild-Type PR and X3 Mutant Promoters (RNA Polymerase Mechanism/Abortive Initiation) DIANE K
    Proc. Natl. Acad. Sci. USA Vol. 77, No. 11, pp. 6381-6385, November 1980 Biochemistry In vitro comparison of initiation properties of bacteriophage X wild-type PR and x3 mutant promoters (RNA polymerase mechanism/abortive initiation) DIANE K. HAWLEY AND WILLIAM R. MCCLURE Department of Biochemistry and Molecular Biology, Conant Laboratory, Harvard University, Cambridge, Massachusetts 02138 Communicated by Mark Ptashne, July 28,1980 ABSTRACT The in vitro initiation properties of the PR Our analysis is based on a simple two-step model of pro- promoter of bacteriophage X and of a PR mutant, x3, were moter-polymerase interaction first proposed by Zillig and his compared. Using the abortive initiation reaction, we measured coworkers (4). According to this model, RNA polymerase first the lags in the approach to a final steady-state rate when dinu- binds to the DNA in a transcriptionally inactive "closed" cleotide synthesis was initiated with RNA polymerase. These unwinds the DNA to form the lags corresponded to the average times required for the forma- complex (RPc) and subsequently tion of transcriptionally active open complexes. By measuring "open" complex (RPO) which then binds the nucleoside tri- the lags at different RNA polymerase concentrations, we could phosphates and initiates transcription (5). Formation of the open separate open complex formation into two steps, based on a complex can be described as follows: simple model in which the initial bimolecular association of free ks k2 promoter and polymerase in a closed complex is followed by an R + Pa SRPco- RPo. [1] isomerization to the open complex. The contribution of each k-1 k-2 step to the overall rate of open complex formation was quanti- tated for both promoters.
    [Show full text]
  • AMPK, Mitochondrial Function, and Cardiovascular Disease
    International Journal of Molecular Sciences Review AMPK, Mitochondrial Function, and Cardiovascular Disease Shengnan Wu * and Ming-Hui Zou Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA 30303, USA; [email protected] * Correspondence: [email protected] Received: 11 June 2020; Accepted: 6 July 2020; Published: 15 July 2020 Abstract: Adenosine monophosphate-activated protein kinase (AMPK) is in charge of numerous catabolic and anabolic signaling pathways to sustain appropriate intracellular adenosine triphosphate levels in response to energetic and/or cellular stress. In addition to its conventional roles as an intracellular energy switch or fuel gauge, emerging research has shown that AMPK is also a redox sensor and modulator, playing pivotal roles in maintaining cardiovascular processes and inhibiting disease progression. Pharmacological reagents, including statins, metformin, berberine, polyphenol, and resveratrol, all of which are widely used therapeutics for cardiovascular disorders, appear to deliver their protective/therapeutic effects partially via AMPK signaling modulation. The functions of AMPK during health and disease are far from clear. Accumulating studies have demonstrated crosstalk between AMPK and mitochondria, such as AMPK regulation of mitochondrial homeostasis and mitochondrial dysfunction causing abnormal AMPK activity. In this review, we begin with the description of AMPK structure and regulation, and then focus on the recent advances toward understanding how mitochondrial dysfunction controls AMPK and how AMPK, as a central mediator of the cellular response to energetic stress, maintains mitochondrial homeostasis. Finally, we systemically review how dysfunctional AMPK contributes to the initiation and progression of cardiovascular diseases via the impact on mitochondrial function. Keywords: mitochondrial function; AMPK; cardiovascular disease 1. Introduction Cells constantly coordinate their metabolism to satisfy their energy needs and respond to the use of nutrients.
    [Show full text]
  • Mito-Cytosolic Translational Balance Increased Cytoprotection And
    Graphical Abstract Worms Human cells Mice Mito-cytosolic translational balance Genetically mrps-5 RNAi Mitochondrial Cytosolic ribosomes ribosomes ATF4/atf-5 Doxycycline Pharmacologically Increased cytoprotection and longevity Manuscript A conserved mito-cytosolic translational balance links two longevity pathways Marte Molenaars1*, Georges E. Janssens1*, Evan G. Williams2, Aldo Jongejan3, Jiayi Lan2, Sylvie Rabot4, Fatima Joly4, Perry D. Moerland3, Bauke V. Schomakers1,5, Marco Lezzerini1 Yasmine J. Liu1, Mark A. McCormick6,7, Brian K. Kennedy8,9, Michel van Weeghel1,5, Antoine H.C. van Kampen3, Ruedi Aebersold2,10, Alyson W. MacInnes1, Riekelt H. Houtkooper1,11# 1Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands 2Institute of Molecular Systems Biology, ETH Zurich, Zürich, Switzerland 3Bioinformatics Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 4Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France 5Core Facility Metabolomics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 6 Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, USA 7Autophagy, Inflammation, and Metabolism Center of Biological Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, USA 8Buck Institute for Research on Aging, Novato, USA 9Departments
    [Show full text]
  • Molecular Mechanisms of Nucleosome Positioning and DNA Methylation in Chromatin
    Molecular mechanisms of nucleosome positioning and DNA methylation in chromatin Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) der Naturwissenschaftlichen Fakultät III - Biologie und vorklinische Medizin der Universität Regensburg durchgeführt am Lehrstuhl für Biochemie III der Universität Regensburg vorgelegt von: ANNA SCHRADER SENSERSTR. 8 81371 MÜNCHEN Abgabedatum: 29. Juli 2009 Die vorliegende Arbeit wurde unter der Betreuung von Prof. Dr. Gernot Längst in der Zeit von Februar 2006 bis Juli 2009 am Institut für Biochemie III der Universität Regensburg erstellt. Prüfungskomitee: Vorsitzender: Prof. Dr. Reinhard Wirth 1. Gutachter: Prof. Dr. Gernot Längst 2. Gutachter: Prof. Dr. Alexander Brehm 3. Gutachter (Prüfer): Prof. Dr. Ralf Wagner Ersatzprüfer: Prof. Dr. Michael Thomm Table of Contents Abbreviations........................................................................................... 1 A. Zusammenfassung ............................................................................... 5 B. Introduction ........................................................................................ 7 I. The Chromatin structure ............................................................................................ 7 1. In General ......................................................................................................................... 7 1.1. The nucleosome - basic packaging unit of chromatin.................................................. 7 1.2. Chromatin higher order structures
    [Show full text]
  • Mitochondrial Misreading in Skeletal Muscle Accelerates Metabolic Aging and Confers Lipid Accumulation and Increased Inflammation
    Downloaded from rnajournal.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REPORT Mitochondrial misreading in skeletal muscle accelerates metabolic aging and confers lipid accumulation and increased inflammation DIMITRI SHCHERBAKOV,1,4 STEFAN DUSCHA,1,4 REDA JUSKEVICIENE,1 LISA M. RESTELLI,2 STEPHAN FRANK,2 ENDRE LACZKO,3 and ERIK C. BÖTTGER1 1Institut für Medizinische Mikrobiologie, Universität Zürich, 8006 Zürich, Switzerland 2Division of Neuropathology, Institute of Medical Genetics and Pathology, Basel University Hospital, 4031 Basel, Switzerland 3Functional Genomics Center Zurich, ETH Zürich und Universität Zürich, 8057 Zürich, Switzerland ABSTRACT We have recently reported on an experimental model of mitochondrial mistranslation conferred by amino acid exchange V338Y in mitochondrial ribosomal protein MrpS5. Here we used a combination of RNA-seq and metabolic profiling of ho- mozygous transgenic Mrps5V338Y/V338Y mice to analyze the changes associated with the V338Y mutation in postmitotic skeletal muscle. Metabolome analysis demonstrated enhanced levels of age-associated metabolites in the mutant V338Y animals accompanied by increased glycolysis, lipid desaturation and eicosanoid biosynthesis, and alterations of the pentose phosphate pathway. In addition, transcriptome signatures of aged V338Y mutant muscle pointed to elevated inflammation, likely reflecting the increased levels of bioactive lipids. Our findings indicate that mistranslation-mediated impairment of mitochondrial function affects specific bioenergetic processes in muscle in an age-dependent manner. Keywords: mitochondria; misreading; skeletal muscle; aging; metabolome INTRODUCTION express a mtDNA mutator phenotype, with a threefold to fivefold increase in the levels of random point mutations A decline in mitochondrial function has been associated in mtDNA, display respiratory chain dysfunction and fea- with aging and complex age-related changes in metabo- tures of accelerated aging (Trifunovic et al.
    [Show full text]
  • 1 Title 1 Discovery of a Small Molecule That Inhibits Bacterial Ribosome Biogenesis 2 3 Authors and Affiliations 4 Jonathan M. S
    1 Title 2 Discovery of a small molecule that inhibits bacterial ribosome biogenesis 3 4 Authors and Affiliations 5 Jonathan M. Stokes1, Joseph H. Davis2, Chand S. Mangat1, James R. Williamson2, and Eric D. Brown1* 6 7 1Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and 8 Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada, L8N 3Z5 9 2Department of Integrative Structural and Computational Biology, Department of Chemistry and The Skaggs 10 Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA 11 12 Contact 13 *Correspondence: [email protected] 14 15 Competing Interests Statement 16 All authors declare no competing interests. 17 18 Impact Statement 19 We report the discovery of a small molecule inhibitor of bacterial ribosome biogenesis. The first probe of its 20 kind, this compound revealed an unexplored role for IF2 in ribosome assembly. 21 22 Major Subject Areas 23 Biochemistry; Microbiology and infectious disease 24 25 Keywords 26 Cold sensitivity; ribosome biogenesis; lamotrigine; translation initiation factor IF2 27 28 1 29 Abstract 30 While small molecule inhibitors of the bacterial ribosome have been instrumental in understanding protein 31 translation, no such probes exist to study ribosome biogenesis. We screened a diverse chemical collection 32 that included previously approved drugs for compounds that induced cold sensitive growth inhibition in the 33 model bacterium Escherichia coli. Among the most cold sensitive was lamotrigine, an anticonvulsant drug. 34 Lamotrigine treatment resulted in the rapid accumulation of immature 30S and 50S ribosomal subunits at 35 15°C. Importantly, this was not the result of translation inhibition, as lamotrigine was incapable of perturbing 36 protein synthesis in vivo or in vitro.
    [Show full text]
  • The Interactome of the Yeast Mitochondrial Ribosome
    The interactome of the yeast mitochondrial ribosome Organization of mitochondrial post-transcriptional regulation, membrane protein insertion and quality control Braulio Vargas Möller-Hergt Academic dissertation for the Degree of Doctor of Philosophy in Biochemistry at Stockholm University to be publicly defended on Friday 19 October 2018 at 13.00 in Magnélisalen Kemiska övningslaboratoriet, Svante Arrhenius väg 16 B. Abstract The proteins found in mitochondria originate from two different genetic systems. Most mitochondrial proteins are synthesized in the cytosol and post-translationally imported into the organelle. However, a small subset of mitochondrial proteins is encoded in an organelle-resident genome. Mitochondria contain factors responsible for replication, transcription and, most important for this thesis, synthesis of the mitochondrially encoded proteins. In the course of evolution the mitochondria specific ribosomes were extensively remodeled. The reasons for many of these adaptations are currently not well understood. For example, the mitoribosome is less stable and abundant than its bacterial counterpart. Therefore, I contributed in the development of robust biochemical tools in order to isolate and analyze the intact yeast mitoribosome and interaction partners by mass spectrometry. The results revealed a higher order organization of mitochondrial gene expression in complexes that we termed MIOREX (mitochondrial organization of gene expression). Besides the mitoribosome, MIOREX complexes contain factors involved in all steps of gene expression. This study also established many new ribosomal interaction partners, among them some proteins that were previously completely uncharacterized. In order to study these proteins, I refined the mass spectrometry approach, allowing a subunit-specific assignment of ribosomal interaction partners. The Mrx15 protein was determined by this approach as an interactor of the large subunit.
    [Show full text]
  • Nucleolin and Its Role in Ribosomal Biogenesis
    NUCLEOLIN: A NUCLEOLAR RNA-BINDING PROTEIN INVOLVED IN RIBOSOME BIOGENESIS Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Julia Fremerey aus Hamburg Düsseldorf, April 2016 2 Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: Prof. Dr. A. Borkhardt Korreferent: Prof. Dr. H. Schwender Tag der mündlichen Prüfung: 20.07.2016 3 Die vorgelegte Arbeit wurde von Juli 2012 bis März 2016 in der Klinik für Kinder- Onkologie, -Hämatologie und Klinische Immunologie des Universitätsklinikums Düsseldorf unter Anleitung von Prof. Dr. A. Borkhardt und in Kooperation mit dem ‚Laboratory of RNA Molecular Biology‘ an der Rockefeller Universität unter Anleitung von Prof. Dr. T. Tuschl angefertigt. 4 Dedicated to my family TABLE OF CONTENTS 5 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................... 5 LIST OF FIGURES ......................................................................................................10 LIST OF TABLES .......................................................................................................12 ABBREVIATION .........................................................................................................13 ABSTRACT ................................................................................................................19 ZUSAMMENFASSUNG
    [Show full text]
  • Mechanism for IL-15–Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins
    Mechanism for IL-15−Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins This information is current as of September 23, 2021. Rashmi Gupta, Wentian Li, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi and Patricia K. A. Mongini J Immunol 2019; 202:2924-2944; Prepublished online 15 April 2019; Downloaded from doi: 10.4049/jimmunol.1801142 http://www.jimmunol.org/content/202/10/2924 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2019/04/14/jimmunol.180114 Material 2.DCSupplemental References This article cites 125 articles, 55 of which you can access for free at: http://www.jimmunol.org/content/202/10/2924.full#ref-list-1 Why The JI? Submit online. by guest on September 23, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]